Your purchase helps support NPR programming. He attended the United States Military Academy, New York University, and received a Michener Fellowship for fiction writing from the University of Texas.Close overlay Buy Featured Book Title Bad Blood Subtitle Secrets and Lies in a Silicon Valley Startup Author John Carreyrou Blaise's media appearances include such television shows as “Today” and “The View” as well as programs on NPR and CNN.
His short stories and poems also have won several honors. An award-winning writer and editor, his journalism has appeared in the New Yorker, WIRED, Conde Nast Portfolio, Forbes, and other publications. Carreyrou lives in Brooklyn, New York, with his wife and three children.īlaise Zerega is managing editor of Alta. Bad Blood was named the Financial Times and McKinsey Business Book of the Year. For his extensive coverage of Theranos, Carreyrou was awarded the George Polk Award for Financial Reporting, the Gerald Loeb Award for Distinguished Business and Financial Journalism in the category of beat reporting, and the Barlett & Steele Silver Award for Investigative Business Journalism. John Carreyrou, a two-time Pulitzer Prize winner, was a reporter at The Wall Street Journal for twenty years. Rigorously reported and fearlessly written, Bad Blood is a gripping story of the biggest corporate fraud since Enron-a tale of ambition and hubris set amid the bold promises of Silicon Valley. All the while, Holmes and her partner, Sunny Balwani, worked to silence anyone who voiced misgivings-from journalists to their own employees.
Erroneous results put patients in danger, leading to misdiagnoses and unnecessary treatments. There was just one problem: The technology didn’t work. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes’s worth at an estimated $4.5 billion. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the next Steve Jobs: a brilliant Stanford dropout whose startup “unicorn” promised to revolutionize the medical industry with its breakthrough device, which performed the whole range of laboratory tests from a single drop of blood. Please note: Tickets are available for purchase at the door! Angelico Hall, Dominican University of California
0 kommentar(er)
